Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bicycle Therapeutics PLC (ADR) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BCYC
Nasdaq
8731
https://www.bicycletherapeutics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bicycle Therapeutics PLC (ADR)
Upgrade: Analysts Just Made A Massive Increase To Their Bicycle Therapeutics plc (NASDAQ:BCYC) Forecasts
- May 7th, 2024 11:02 am
Bicycle Therapeutics (BCYC) Moves to Buy: Rationale Behind the Upgrade
- May 6th, 2024 4:00 pm
Wall Street Analysts See a 77.22% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High?
- May 6th, 2024 1:55 pm
Bicycle Therapeutics First Quarter 2024 Earnings: Beats Expectations
- May 4th, 2024 2:11 pm
Bicycle Therapeutics PLC (BCYC) Q1 2024 Earnings: Narrowing Losses Amidst Robust R&D Progress
- May 2nd, 2024 12:44 pm
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
- May 2nd, 2024 11:00 am
Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
- Apr 24th, 2024 2:05 pm
Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Apr 2nd, 2024 11:00 am
Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
- Mar 5th, 2024 9:35 pm
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
- Feb 28th, 2024 12:00 pm
Earnings Update: Bicycle Therapeutics plc (NASDAQ:BCYC) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
- Feb 23rd, 2024 11:51 am
Bicycle Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
- Feb 21st, 2024 7:25 pm
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
- Feb 20th, 2024 12:05 pm
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Feb 7th, 2024 12:00 pm
15 Small-Cap Stocks with High Potential
- Jan 22nd, 2024 3:54 pm
Bicycle Therapeutics PLC CEO Kevin Lee Sells 8,703 Shares
- Jan 5th, 2024 7:02 am
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
- Dec 14th, 2023 12:00 pm
Bicycle Therapeutics to Host R&D Day on December 14
- Nov 30th, 2023 12:00 pm
Bicycle Therapeutics plc (NASDAQ:BCYC) Analysts Just Trimmed Their Revenue Forecasts By 13%
- Nov 7th, 2023 10:02 am
Bicycle Therapeutics PLC (BCYC) Reports Q3 2023 Financial Results and Upcoming R&D Day
- Nov 2nd, 2023 12:46 pm
Scroll